ABCB6 and diffuse large B-cell lymphoma: Unlike lenalidomide, avadomide, a next-generation IMiDs, has shown direct apoptotic activity in DLBCL cells and promising clinical activity in R/R DLBCL patients with both GCB- and ABC-DLBCL subtypes [211].